Literature DB >> 21187392

Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma.

Chiara Braconi1, Nicola Valeri, Takayuki Kogure, Pierluigi Gasparini, Nianyuan Huang, Gerard J Nuovo, Luigi Terracciano, Carlo M Croce, Tushar Patel.   

Abstract

Although expression of non-protein-coding RNA (ncRNA) can be altered in human cancers, their functional relevance is unknown. Ultraconserved regions are noncoding genomic segments that are 100% conserved across humans, mice, and rats. Conservation of gene sequences across species may indicate an essential functional role, and therefore we evaluated the expression of ultraconserved RNAs (ucRNA) in hepatocellular cancer (HCC). The global expression of ucRNAs was analyzed with a custom microarray. Expression was verified in cell lines by real-time PCR or in tissues by in situ hybridization using tissue microarrays. Cellular ucRNA expression was modulated with siRNAs, and the effects on global gene expression and growth of human and murine HCC cells were evaluated. Fifty-six ucRNAs were aberrantly expressed in HepG2 cells compared with nonmalignant hepatocytes. Among these ucRNAs, the greatest change was noted for ultraconserved element 338 (uc.338), which was dramatically increased in human HCC compared with noncancerous adjacent tissues. Although uc.338 is partially located within the poly(rC) binding protein 2 (PCBP2) gene, the transcribed ncRNA encoding uc.338 is expressed independently of PCBP2 and was cloned as a 590-bp RNA gene, termed TUC338. Functional gene annotation analysis indicated predominant effects on genes involved in cell growth. These effects were experimentally demonstrated in both human and murine cells. siRNA to TUC338 decreased both anchorage-dependent and anchorage-independent growth of HCC cells. These studies identify a critical role for TUC338 in regulation of transformed cell growth and of transcribed ultraconserved ncRNA as a unique class of genes involved in the pathobiology of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187392      PMCID: PMC3021052          DOI: 10.1073/pnas.1011098108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Authors:  H Azechi; N Nishida; Y Fukuda; T Nishimura; M Minata; H Katsuma; M Kuno; T Ito; T Komeda; R Kita; R Takahashi; K Nakao
Journal:  Oncology       Date:  2001       Impact factor: 2.935

2.  Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.

Authors:  Katrin Panzitt; Marisa M O Tschernatsch; Christian Guelly; Tarek Moustafa; Martin Stradner; Heimo M Strohmaier; Charles R Buck; Helmut Denk; Renée Schroeder; Michael Trauner; Kurt Zatloukal
Journal:  Gastroenterology       Date:  2006-08-14       Impact factor: 22.682

3.  Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants.

Authors:  Adnan Derti; Frederick P Roth; George M Church; C-ting Wu
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

Review 4.  Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies.

Authors:  Jessica Zucman-Rossi; Pierre Laurent-Puig
Journal:  Pharmacogenomics       Date:  2007-08       Impact factor: 2.533

5.  Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Authors:  Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Jennifer Altomonte; Alexandra Junger; Günter Schneider; Wolfgang E Thasler; Nobuyuki Kato; Roland M Schmid; Oliver Ebert
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

6.  Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.

Authors:  Sylwia E Wojcik; Simona Rossi; Masayoshi Shimizu; Milena S Nicoloso; Amelia Cimmino; Hansjuerg Alder; Vlad Herlea; Laura Z Rassenti; Kanti R Rai; Thomas J Kipps; Michael J Keating; Carlo M Croce; George A Calin
Journal:  Carcinogenesis       Date:  2009-11-19       Impact factor: 4.944

Review 7.  Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

Authors:  Yutaka Midorikawa; Masatoshi Makuuchi; Wei Tang; Hiroyuki Aburatani
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

9.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Authors:  Laura Gramantieri; Manuela Ferracin; Francesca Fornari; Angelo Veronese; Silvia Sabbioni; Chang-Gong Liu; George A Calin; Catia Giovannini; Eros Ferrazzi; Gian Luca Grazi; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 10.  The genetic signatures of noncoding RNAs.

Authors:  John S Mattick
Journal:  PLoS Genet       Date:  2009-04-24       Impact factor: 5.917

View more
  110 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 2.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

3.  RNAcentral: A vision for an international database of RNA sequences.

Authors:  Alex Bateman; Shipra Agrawal; Ewan Birney; Elspeth A Bruford; Janusz M Bujnicki; Guy Cochrane; James R Cole; Marcel E Dinger; Anton J Enright; Paul P Gardner; Daniel Gautheret; Sam Griffiths-Jones; Jen Harrow; Javier Herrero; Ian H Holmes; Hsien-Da Huang; Krystyna A Kelly; Paul Kersey; Ana Kozomara; Todd M Lowe; Manja Marz; Simon Moxon; Kim D Pruitt; Tore Samuelsson; Peter F Stadler; Albert J Vilella; Jan-Hinnerk Vogel; Kelly P Williams; Mathew W Wright; Christian Zwieb
Journal:  RNA       Date:  2011-09-22       Impact factor: 4.942

4.  The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.

Authors:  Hao-Long Qi; Chang-Sheng Li; Chong-Wei Qian; Yu-Sha Xiao; Yu-Feng Yuan; Quan-Yan Liu; Zhi-Su Liu
Journal:  Tumour Biol       Date:  2015-08-14

5.  Expression of transcribed ultraconserved regions of genome in rat cerebral cortex.

Authors:  Suresh L Mehta; Ashutosh Dharap; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2014-06-20       Impact factor: 3.921

Review 6.  Regulation of mammalian DNA methyltransferases: a route to new mechanisms.

Authors:  Hélène Denis; Matladi N Ndlovu; François Fuks
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

7.  Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.

Authors:  Yunzhen Gao; Geng Chen; Yongyi Zeng; Jinhua Zeng; Minjie Lin; Xiaolong Liu; Jingfeng Liu
Journal:  Tumour Biol       Date:  2015-04-22

Review 8.  Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.

Authors:  John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2017-05-18       Impact factor: 22.682

Review 9.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

10.  Modulation of hypoxia-signaling pathways by extracellular linc-RoR.

Authors:  Kenji Takahashi; Irene K Yan; Hiroaki Haga; Tushar Patel
Journal:  J Cell Sci       Date:  2014-01-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.